The Dutch Cancer Society (KWF) has awarded 8 grants to Radboudumc researchers. We congratulate them with this funding and wish them success with their great work.
Research project: Focus on values to stimulate shared decisions in patients with thyroid cancer: A multifaceted COMmunication BOoster (COMBO).
Peep Stalmeier, theme Womens's cancers, RIHS
Approved budget: € 508,428
Research project: Phase IIa study of ex vivo-generated allogeneic NK cell infusion in combination with subcutaneous IL-15 superagonist ALT-803 in relapsed/refractory AML patients.
Harry Dolstra, theme Cancer development and immune defense, RIMLS
Approved budget: € 1,294,415
Research project: Galactin-9 is required for Dendritic Cell function during anti-melanoma immunity.
Annemiek van Spriel, theme Cancer development and immune defense, RIMLS
Approved budget: € 623,515
Research project: FORwards: Feasibility and effectiveness Of Real-world use of the SWORD evidence-based
psychological intervention for fear of cancer recurrence.
Judith Prins, theme Women's cancers, RIHS
Approved budget: € 453,919
Young Investigator grant:
Research project: Understanding brain mechanisms of cancer-related fatigue: a sickness-behaviour approach.
Marieke van der Schaaf, theme Stress related disorders, DCMN
Approved budget: € 632,612
Unique high risk project:
Research project: The cell by cell measuring of the response to therapy to detect resistant cells.
Klaas Mulder, theme Cancer development and immune defense, RIMLS
Approved budget: € 220,646
Research project: STOPOVCA: STOP OVarian CAncer: the implementation of opportunistic salpingectomy to prevent ovarian cancer.
Joanne de Hullu, theme Women's cancers, RIHS
Approved budget: € 416,684
Research project: ImplemenTation of concentration gUided dosing to optimize treatmeNt outcomE in patients treated with oral targeted anticancer drugs (TUNE project).
Ingrid Desar, theme Rare cancers, RIHS
Approved budget: € 683,113
Go to the Dutch Cancer Society website (KWF).
Related news items
Two projects granted for experimental Rheumatology22 October 2019
Osteoarthritis is the most prevalent and debilitating joint disease worldwide but no cure has been developed yet. Recent findings show that low grade inflammation within the OA joint contributes to the pathophysiology and clinical symptoms.read more
Radboud Bioinformatics Xmas event 16 December21 October 2019
The CMBI is organizing the event of the year for all bioinformaticians throughout Radboud University and Radboudumc to give you the opportunity to bring forward the biggest challenges in your research to expert bioinformaticians and pave the way for real solutions.read more
Merel Ritskes-Hoitinga has been appointed honorary Skou professor at Aarhus University17 October 2019
Merel Ritskes-Hoitinga has been appointed honorary Skou Professor at the Dept. of Clinical Medicine, at Aarhus University. The aim is to introduce new perspectives to teaching, strengthen relations with leading research units abroad and establish joint research projects and funding applications.read more